CompletedNCT01342445
Official study titleEffects of Vyvanse on the Behavioral, Academic, and Psychosocial Functioning of College Students With ADHD
This study has finished and is no longer accepting participants.
Multiple locations, including BethlehemADHDMedication studyAges 18–28
- Countries
- United States
- Sponsor
- University of Rhode Island
CompletedNCT07521449
Official study titleDifferential Cognitive Effects of DHA-Enriched and Standard Phosphatidylserine Formulations in Children With ADHD: A Randomized Placebo-Controlled Trial
This study has finished and is no longer accepting participants.
In IstanbulADHDPlacebo comparisonAges 10–14
- Countries
- Türkiye
- Sponsor
- Çağlar Charles Daniel Jaicks
CompletedNCT02685254
Official study titleEffects of Structured Skills Training Group in Treatment of ADHD in Adults: a Controlled Multicentre Study
This study has finished and is no longer accepting participants.
In TønsbergADHDBehavioural studyAges 18+
- Countries
- Norway
- Sponsor
- University of Oslo
CompletedNCT04880304
Official study titleEffects of Subconcussive Head Impacts on Neural Integrity and Function in ADHD: a Case-control Intervention
This study has finished and is no longer accepting participants.
In BloomingtonADHDInterventional studyAges 18–26
- Countries
- United States
- Sponsor
- Indiana University
CompletedNCT00467428
What is this study about?This study evaluated the safety and effectiveness of NS2359 for people with ADHD.
This study has finished and is no longer accepting participants.
In BostonADHDMedication studyAges 18–55
- Countries
- United States
- Sponsor
- NeuroSearch A/S
CompletedNCT02633527
Official study titleEvaluation of the Efficacy and Safety of SPN-812 (Viloxazine Extended-release Capsule) in Children With ADHD - A Double-Blind, Placebo-Controlled, Dose-Ranging Study
This study has finished and is no longer accepting participants.
In MaitlandADHDMedication studyAges 6–12
- Countries
- United States
- Sponsor
- Supernus Pharmaceuticals, Inc. (Pharmaceutical company)
CompletedNCT01919073
This study has finished and is no longer accepting participants.
In HoustonADHDBehavioural studyAges 2–5
- Countries
- United States
- Sponsor
- Baylor College of Medicine
CompletedNCT02150668
This study has finished and is no longer accepting participants.
In RichmondADHDBehavioural studyAges 11–15
- Countries
- United States
- Sponsor
- Virginia Commonwealth University
CompletedNCT01985581
Official study titleA Single-Center, Randomized, Double Blind, Placebo-Controlled, Crossover Evaluation of the Effect of GXR as Adjunctive Treatment With Stimulant on Executive Function and Quality of Life at Home and School in Children With ADHD
This study has finished and is no longer accepting participants.
In OttawaADHDMedication studyAges 6–12
- Countries
- Canada
- Sponsor
- JPM van Stralen Medicine Professional
CompletedNCT01883765
Official study titleEfficacy of a Neurofeedback Treatment in Adults With ADHD: a Triple-blind Randomized Placebo-controlled Study
This study has finished and is no longer accepting participants.
In TübingenADHDBehavioural studyAges 18–60
- Countries
- Germany
- Sponsor
- University Hospital Tuebingen
CompletedNCT03685279
Official study titleTesting the Efficacy of the Nurtured Heart Approach: A Randomized Controlled Trial
This study has finished and is no longer accepting participants.
In TucsonADHDBehavioural studyAges 18+
- Countries
- United States
- Sponsor
- University of Arizona
CompletedNCT05374187
Official study titleEfficacy of External Trigeminal Nerve Stimulation for Treatment of ADHD
This study has finished and is no longer accepting participants.
Multiple locations, including Los AngelesADHDDevice studyAges 7–12
- Countries
- United States
- Sponsor
- University of California, Los Angeles